194
Views
39
CrossRef citations to date
0
Altmetric
Review

Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition

, , , &
Pages 1249-1259 | Published online: 06 Sep 2013

References

  • GuJWRizzoPPannutiAGoldeTOsborneBMieleLNotch signals in the endothelium and cancer “stem-like” cells: opportunities for cancer therapyVasc Cell20124722487493
  • PannutiAForemanKRizzoPTargeting Notch to target cancer stem cellsClin Cancer Res201016123141315220530696
  • BlaumuellerCMQiHZagourasPArtavanis-TsakonasSIntracellular cleavage of Notch leads to a heterodimeric receptor on the plasma membraneCell19979022812919244302
  • DunwoodieSLHenriqueDHarrisonSMBeddingtonRSMouse Dll3: a novel divergent Delta gene which may complement the function of other Delta homologues during early pattern formation in the mouse embryoDevelopment19971246306530769272948
  • LindsellCEShawberCJBoulterJWeinmasterGJagged: a mammalian ligand that activates Notch1Cell19958069099177697721
  • ShawberCBoulterJLindsellCEWeinmasterGJagged2: a serrate-like gene expressed during rat embryogenesisDev Biol199618013703768948600
  • CallahanRRaafatANotch signaling in mammary gland tumorigenesisJ Mammary Gland Biol Neoplasia200161233611467450
  • BrouCLogeatFGuptaNA novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACEMol Cell20005220721610882063
  • SaxenaMTSchroeterEHMummJSKopanRMurine notch homologs (N1–4) undergo presenilin-dependent proteolysisJ Biol Chem200127643402684027311518718
  • HsiehJJZhouSChenLYoungDBHaywardSDCIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complexProc Natl Acad Sci U S A199996123289874765
  • WuLAsterJCBlacklowSCLakeRArtavanis-TsakonasSGriffinJDMAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptorsNat Genet200026448448911101851
  • MaierMMGesslerMComparative analysis of the human and mouse Hey1 promoter: Hey genes are new Notch target genesBiochem Biophys Res Commun2000275265266010964718
  • RonchiniCCapobiancoAJInduction of cyclin D1 transcription and CDK2 activity by Notch(ic): implication for cell cycle disruption in transformation by Notch(ic)Mol Cell Biol200121175925593411486031
  • WengAPMillhollandJMYashiro-OhtaniYc-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphomaGenes Dev200620152096210916847353
  • GermarKDoseMKonstantinouTT-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signalingProc Natl Acad Sci U S A201110850200602006522109558
  • CalderwoodMALeeSHolthausAMBlacklowSCKieffEJohannsenEEpstein-Barr virus nuclear protein 3C binds to the N-terminal (NTD) and beta trefoil domains (BTD) of RBP/CSL; only the NTD interaction is essential for lymphoblastoid cell growthVirology20114141192521440926
  • MieleLTranscription factor RBPJ/CSL: a genome-wide look at transcriptional regulationProc Natl Acad Sci U S A201110836147151471621873209
  • KakaralaMWichaMSImplications of the cancer stem-cell hypothesis for breast cancer prevention and therapyJ Clin Oncol200826172813282018539959
  • DontuGJacksonKWMcNicholasEKawamuraMJAbdallahWMWichaMSRole of Notch signaling in cell-fate determination of human mammary stem/progenitor cellsBreast Cancer Res200466R605R61515535842
  • LiuSDontuGMantleIDHedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cellsCancer Res200666126063607116778178
  • LiuSDontuGWichaMSMammary stem cells, self-renewal pathways, and carcinogenesisBreast Cancer Res200573869515987436
  • ReyaTCleversHWnt signalling in stem cells and cancerNature2005434703584385015829953
  • ZagourasPStifaniSBlaumuellerCMCarcangiuMLArtavanis-TsakonasSAlterations in Notch signaling in neoplastic lesions of the human cervixProc Natl Acad Sci U S A19959214641464187604005
  • LeethanakulCPatelVGillespieJDistinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arraysOncogene200019283220322410918578
  • SuzukiTAokiDSusumuNUdagawaYNozawaSImbalanced expression of TAN-1 and human Notch4 in endometrial cancersInt J Oncol20001761131113911078798
  • RaeFKStephensonSANicolDLClementsJANovel association of a diverse range of genes with renal cell carcinoma as identified by differential displayInt J Cancer200088572673211072240
  • DangTPGazdarAFVirmaniAKChromosome 19 translocation, overexpression of Notch3, and human lung cancerJ Natl Cancer Inst200092161355135710944559
  • MiyamotoYMaitraAGhoshBNotch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesisCancer Cell20033656557612842085
  • HopferOZwahlenDFeyMFAebiSThe Notch pathway in ovarian carcinomas and adenomasBr J Cancer200593670971816136053
  • SantagataSDemichelisFRivaAJAGGED1 expression is associated with prostate cancer metastasis and recurrenceCancer Res200464196854685715466172
  • SubramaniamDPonnurangamSRamamoorthyPCurcumin induces cell death in esophageal cancer cells through modulating Notch signalingPloS One201272e3059022363450
  • LiaoSXiaJChenZWangZInhibitory effect of curcumin on oral carcinoma CAL-27 cells via suppression of Notch-1 and NF-kappaB signaling pathwaysJ Cell Biochem201111241055106521308734
  • WangCQiRLiNNotch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expressionJ Biol Chem200928424161831619019376776
  • YehITReddickRLKumarAPMalignancy arising in seminal vesicles in the transgenic adenocarcinoma of mouse prostate (TRAMP) modelProstate200969775576019170049
  • BocchettaMMieleLPassHICarboneMNotch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cellsOncogene2003221818912527910
  • BalintKXiaoMPinnixCCActivation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progressionJ Clin Invest2005115113166317616239965
  • PurowBWHaqueRMNoelMWExpression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferationCancer Res20056562353236315781650
  • FanXMikolaenkoIElhassanINotch1 and notch2 have opposite effects on embryonal brain tumor growthCancer Res200464217787779315520184
  • JundtFAnagnostopoulosIForsterRMathasSSteinHDorkenBActivated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphomaBlood20029993398340311964309
  • TohdaSNaraNExpression of Notch1 and Jagged1 proteins in acute myeloid leukemia cellsLeuk Lymphoma200142346747211699411
  • HubmannRSchwarzmeierJDShehataMNotch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemiaBlood200299103742374711986231
  • HoudeCLiYSongLOverexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell linesBlood2004104123697370415292061
  • JundtFProbstingKSAnagnostopoulosIJagged1-induced Notch signaling drives proliferation of multiple myeloma cellsBlood200410393511351514726396
  • PancewiczJNicotCCurrent views on the role of Notch signaling and the pathogenesis of human leukemiaBMC Cancer20111150222128846
  • RestivoGNguyenBCDziunyczPIRF6 is a mediator of Notch pro-differentiation and tumour suppressive function in keratinocytesEMBO J201130224571458521909072
  • NicolasMWolferARajKNotch1 functions as a tumor suppressor in mouse skinNat Genet200333341642112590261
  • DumortierADurhamADDi PiazzaMAtopic dermatitis-like disease and associated lethal myeloproliferative disorder arise from loss of Notch signaling in the murine skinPloS One201052e925820174635
  • AlbiniASpornMBThe tumour microenvironment as a target for chemopreventionNat Rev Cancer2007213914717218951
  • KongDLiYWangZSarkarFHCancer stem cells and epithelial-mesenchymal transition (EMT)-phenotypic cells: are they cousins or twins?Cancers (Basel)20113171672921643534
  • WangZLiYBanerjeeSSarkarFHEmerging role of Notch in stem cells and cancerCancer Lett2009279181219022563
  • WangZLiYKongDAhmadABanerjeeSSarkarFHCross-talk between miRNA and Notch signaling pathways in tumor development and progressionCancer Lett2010292214114820022691
  • YauchRLJanuarioTEberhardDAEpithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patientsClin Cancer Res20051124 Pt 18686869816361555
  • VoulgariAPintzasAEpithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinicBiochim Biophys Acta200917962759019306912
  • FrederickBAHelfrichBAColdrenCDEpithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinomaMol Cancer Ther2007661683169117541031
  • SabbahMEmamiSRedeuilhGMolecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancersDrug Resist Updat2008114–512315118718806
  • KajiyamaHShibataKTerauchiMChemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cellsInt J Oncol200731227728317611683
  • KonecnyGEVenkatesanNYangGActivity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cellsBr J Cancer20089861076108418334972
  • ShahANSummyJMZhangJParkSIParikhNUGallickGEDevelopment and characterization of gemcitabine-resistant pancreatic tumor cellsAnn Surg Oncol200714123629363717909916
  • YangADFanFCampERChronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell linesClin Cancer Res20061214 Pt 14147415316857785
  • NosedaMMcLeanGNiessenKNotch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformationCirc Res200494791091714988227
  • TimmermanLAGrego-BessaJRayaANotch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformationGenes Dev20041819911514701881
  • BeckerKFRosivatzEBlechschmidtKKremmerESarbiaMHoflerHAnalysis of the E-cadherin repressor Snail in primary human cancersCells Tissues Organs20071851–320421217587826
  • SahlgrenCGustafssonMVJinSPoellingerLLendahlUNotch signaling mediates hypoxia-induced tumor cell migration and invasionProc Natl Acad Sci U S A2008105176392639718427106
  • NiessenKFuYChangLHoodlessPAMcFaddenDKarsanASlug is a direct Notch target required for initiation of cardiac cushion cellularizationJ Cell Biol2008182231532518663143
  • LeongKGNiessenKKulicIJagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherinJ Exp Med2007204122935294817984306
  • NiimiHPardaliKVanlandewijckMHeldinCHMoustakasANotch signaling is necessary for epithelial growth arrest by TGF-betaJ Cell Biol2007176569570717325209
  • ZavadilJCermakLSoto-NievesNBottingerEPIntegration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transitionEMBO J20042351155116514976548
  • WangZLiYKongDAcquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathwayCancer Res20096962400240719276344
  • KongDBanerjeeSAhmadAEpithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cellsPloS One201058e1244520805998
  • Domingo-DomenechJVidalSJRodriguez-BravoVSuppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cellsCancer Cell201222337338822975379
  • van der PluijmGEpithelial plasticity, cancer stem cells and bone metastasis formationBone201148374320670698
  • PapachristouDJBasdraEKPapavassiliouAGBone metastases: molecular mechanisms and novel therapeutic interventionsMed Res Rev201232361163620818675
  • SethiSMacoskaJChenWSarkarFHMolecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasisAm J Transl Res201031909921139809
  • ZhuHZhouXRedfeldSLewinJMieleLElevated Jagged-1 and Notch-1 expression in high grade and metastatic prostate cancersAm J Transl Res20135336837823634247
  • XingFOkudaHWatabeMHypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cellsOncogene201130394075408621499308
  • PittengerMFMackayAMBeckSCMultilineage potential of adult human mesenchymal stem cellsScience1999284541114314710102814
  • SpaethELDembinskiJLSasserAKMesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progressionPloS One2009174e499219352430
  • SanchezCGPenfornisPOskowitzAZActivation of autophagy in mesenchymal stem cells provides tumor stromal supportCarcinogenesis201132796497221317300
  • ProckopDJRepair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigmsMol Ther200917693994619337235
  • HallBAndreeffMMariniFThe participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehiclesHandb Exp Pharmacol200718026328317554513
  • VallabhaneniKCTkachukSKiyanYUrokinase receptor mediates mobilization, migration, and differentiation of mesenchymal stem cellsCardiovasc Res201190111312121088115
  • StudenyMMariniFCChamplinREZompettaCFidlerIJAndreeffMBone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumorsCancer Res200262133603360812097260
  • SchichorCBirnbaumTEtminanNVascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC)Exp Neurol2006199230131016574102
  • BirnbaumTRoiderJSchankinCJMalignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokinesJ Neurooncol200783324124717570034
  • FengBChenLReview of mesenchymal stem cells and tumors: executioner or coconspirator?Cancer Biother Radiopharm200924671772120025552
  • SpaethEKloppADembinskiJAndreeffMMariniFInflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cellsGene Ther2008151073073818401438
  • DwyerRMPotter-BeirneSMHarringtonKAMonocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cellsClin Cancer Res200713175020502717785552
  • KiddSSpaethEKloppAAndreeffMHallBMariniFCThe (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foeCytotherapy200810765766718985472
  • HoganNMDwyerRMJoyceMRKerinMJMesenchymal stem cells in the colorectal tumor microenvironment: recent progress and implicationsInt J Cancer201213111722290082
  • ZhuWXuWJiangRMesenchymal stem cells derived from bone marrow favor tumor cell growth in vivoExp Mol Pathol200680326727416214129
  • DjouadFPlencePBonyCImmunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animalsBlood2003102103837384412881305
  • MaoYKellerETGarfeldDHShenKWangJStromal cells in tumor microenvironment and breast cancerCancer Metastasis Rev2013321–230331523114846
  • Early Breast Cancer Trialists’ Collaborative Group (EBCTCG); DaviesCGodwinJRelevance of breast cancer hormone receptors and other factors to the effiacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trialsLancet2011378979377178421802721
  • MartinFTDwyerRMKellyJPotential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT)Breast Cancer Res Treat2010124231732620087650
  • KandouzMBatistGGap junctions and connexins as therapeutic targets in cancerExpert Opin Ther Targets201014768169220446866
  • MroueRMEl-SabbanMETalhoukRSConnexins and the gap in contextIntegr Biol (Camb)20113425526621437329
  • GilleronJCaretteDChevallierDSegretainDPointisGMolecular connexin partner remodeling orchestrates connexin traffic: from physiology to pathophysiologyCrit Rev Biochem Mol Biol201247540742322551357
  • GuJQianHShenLGastric cancer exosomes trigger differentiation of umbilical cord derived mesenchymal stem cells to carcinoma-associated fibroblasts through TGF-beta/Smad pathwayPloS One2012712e5246523285052
  • BonnometABrysseATachsidisAEpithelial-to-mesenchymal transitions and circulating tumor cellsJ Mammary Gland Biol Neoplasia201015226127320449641
  • JingYHanZZhangSLiuYWeiLEpithelial-mesenchymal transition in tumor microenvironmentCell Biosci201112921880137
  • LiHJReinhardtFHerschmanHRWeinbergRACancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signalingCancer Discov20122984085522763855
  • HuangFZhuXHuXQMesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survivalInt J Mol Med201331248449223229021
  • XieJWangWSiJWNotch signaling regulates CXCR4 expression and the migration of mesenchymal stem cellsCell Immunol20132811687523474530
  • Del PapaBSportolettiPCecchiniDNotch1 modulates mesenchymal stem cells mediated regulatory T-cell inductionEur J Immunol201343118218723161436
  • EnginFYaoZYangTDimorphic effects of Notch signaling in bone homeostasisNat Med200814329930518297084
  • SethiNDaiXWinterCGKangYTumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cellsCancer Cell201119219220521295524
  • WhitesideTLThe tumor microenvironment and its role in promoting tumor growthOncogene200827455904591218836471
  • JoyceJAPollardJWMicroenvironmental regulation of metastasisNat Rev Cancer20099423925219279573
  • McGowanPMSimedreaCRibotEJNotch1 inhibition alters the CD44hi/CD24lo population and reduces the formation of brain metastases from breast cancerMol Cancer Res20119783484421665937
  • RohnerASpilkerMELamJLEffective targeting of Hedgehog signaling in a medulloblastoma model with PF-5274857, a potent and selective Smoothened antagonist that penetrates the blood-brain barrierMol Cancer Ther2012111576522084163
  • BleckmannASiamLKlemmFNuclear LEF1/TCF4 correlate with poor prognosis but not with nuclear β-catenin in cerebral metastasis of lung adenocarcinomasClin Exp Metastasis201230447148223224985
  • ZengQLiSChepehaDBCrosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signalingCancer Cell200581132316023595
  • PolicastroLLIbañezILNotcovichCDuranHAPodhajcerOLThe tumor microenvironment: characterization, redox considerations, and novel approaches for reactive oxygen species-targeted gene therapyAntioxid Redox Signal Epub1022012
  • FiaschiTChiarugiPOxidative stress, tumor microenvironment, and metabolic reprogramming: a diabolic liaisonInt J Cell Biol2012201276282522666258
  • PietrasAvon StedingkKLindgrenDPahlmanSAxelsonHJAG2 induction in hypoxic tumor cells alters Notch signaling and enhances endothelial cell tube formationMol Cancer Res20119562663621402725
  • XingFKobayashiAOkudaHReactive astrocytes promote the metastatic growth of breast cancer stem-like cells by activating Notch signalling in brainEMBO Mol Med20135338439623495140
  • RidgwayJZhangGWuYInhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesisNature200644471221083108717183323
  • Noguera-TroiseIDalyCPapadopoulosNJBlockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesisNature200644471221032103717183313
  • ScehnetJSJiangWKumarSRInhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusionBlood2007109114753476017311993
  • ThurstonGNoguera-TroiseIYancopoulosGDThe Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growthNat Rev Cancer20077532733117457300
  • YanMPlowmanGDDelta-like 4/Notch signaling and its therapeutic implicationsClin Cancer Res200713247243724618094402
  • ReynoldsNDLukacsNWLongNKarpusWJDelta-like ligand 4 regulates central nervous system T cell accumulation during experimental autoimmune encephalomyelitisJ Immunol201118752803281321788444
  • HayashiITakatoriSUranoYNeutralization of the gamma-secretase activity by monoclonal antibody against extracellular domain of nicastrinOncogene201231678779821725355
  • FunahashiYHernandezSLDasIA notch1 ectodomain construct inhibits endothelial notch signaling, tumor growth, and angiogenesisCancer Res200868124727473518559519
  • Varnum-FinneyBWuLYuMImmobilization of Notch ligand, Delta-1, is required for induction of notch signalingJ Cell Sci2000113Pt 234313431811069775
  • SmallDKovalenkoDKacerDSoluble Jagged 1 represses the function of its transmembrane form to induce the formation of the Src-dependent chord-like phenotypeJ Biol Chem200127634320223203011427524
  • SmasCMChenLSulHSCleavage of membrane-associated pref-1 generates a soluble inhibitor of adipocyte differentiationMol Cell Biol19971729779889001251
  • MoelleringRECornejoMDavisTNDirect inhibition of the NOTCH transcription factor complexNature2009462727018218819907488
  • TammamJWareCEffersonCDown-regulation of the Notch pathway mediated by a gamma-secretase inhibitor induces anti-tumour effects in mouse models of T-cell leukaemiaBr J Pharmacol200915851183119519775282
  • WeiPWallsMQiuMEvaluation of selective gamma-secretase inhibitor PF-03084014 for its antitumor efficacy and gastrointestinal safety to guide optimal clinical trial designMol Cancer Ther2010961618162820530712
  • FouladiMStewartCFOlsonJPhase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium studyJ Clin Oncol201129263529353421825264
  • PandyaKMeekeKClementzAGTargeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrenceBr J Cancer2011105679680621847123
  • MacyMESawczynKKGarringtonTPGrahamDKGoreLPediatric developmental therapies: interesting new drugs now in early-stage clinical trialsCurr Oncol Rep200810647749018928662
  • Zweidler-McKayPANotch signaling in pediatric malignanciesCurr Oncol Rep200810645946818928660
  • ZhouBBZhangHDamelinMGelesKGGrindleyJCDirksPBTumour-initiating cells: challenges and opportunities for anticancer drug discoveryNat Rev Drug Discov200981080682319794444
  • KallifatidisGLabschSRauschVSulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostateMol Ther201119118819520940707
  • KawaharaTKawaguchi-IharaNOkuhashiYItohMNaraNTohdaSCyclopamine and quercetin suppress the growth of leukemia and lymphoma cellsAnticancer Res200929114629463220032413
  • OkuhashiYItohMNaraNTohdaSEffects of combination of notch inhibitor plus hedgehog inhibitor or Wnt inhibitor on growth of leukemia cellsAnticancer Res201131389389621498710
  • ZhouWKallifatidisGBaumannBDietary polyphenol quercetin targets pancreatic cancer stem cellsInt J Oncol201037355156120664924
  • WangZZhangYBanerjeeSLiYSarkarFHNotch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cellsCancer2006106112503251316628653
  • LuistroLHeWSmithMPreclinical profile of a potent gamma-secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic propertiesCancer Res200969197672768019773430
  • RaoSSO’NeilJLiberatorCDInhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cellsCancer Res20096973060306819318552
  • EspinozaIMieleLNotch inhibitors for cancer treatmentPharmacol Ther201313929511023458608
  • HarrisonHFarnieGHowellSJRegulation of breast cancer stem cell activity by signaling through the Notch4 receptorCancer Res201070270971820068161
  • SamonJBCastillo-MartinMHadlerMPreclinical analysis of the gamma-secretase inhibitor PF-03084014 in combination with glucocorticoids in T-cell acute lymphoblastic leukemiaMol Cancer Ther20121171565157522504949
  • RizzoPMiaoHD’SouzaGCross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approachesCancer Res200868135226523518593923
  • AlbainKCzerlanisCZlobinAModulation of cancer stem cell biomarkers by the Notch inhibitor MK-0752 added to endocrine therapy for early stage ER+ breast cancerCancer Res20117197s
  • Means-PowellJAMintonSEMayerIAA Phase Ib dose escalation trial of RO4929097 (a γ-secretase inhibitor) in combination with exemestane in patients with ER + metastatic breast cancerCancer Res201272280s
  • JieunYunPannutiAPEspinozaICrosstalk between PKCα and Notch-4 in endocrine-resistant breast cancer cellsOncogenesis2013
  • SchottAFLandisMDDontuGPreclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumorsClin Cancer Res20131961512152423340294